Pharmacotherapy

Title Average Ratingsort ascending
The Deep Gluteal Syndrome, an underestimated etiological factor for Sciatica, Low Back Pain and other chronic pain conditions? 100.00%
Why is not Ukrain approved yet in Austria/EU? 98.57%
Ukrain (NSC-631570) in the treatment of pancreas cancer. 95.00%
Reducing malignant ascites accumulation by repeated intraperitoneal administrations of a Viscum album extract. 95.00%
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. 95.00%
WHO’S AFRAID OF A CURE FOR CANCER? - The struggle for an alternative cancer drug 90.00%
Clinical Investigations on Ukrain 90.00%
Ukrain - a new cancer cure? A systematic review of randomised clinical trials. 90.00%
Retrospective study of Ukrain treatment in 203 patients with advanced-stage tumors 90.00%
Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (Iscador). 90.00%
Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity........... 90.00%
Debate in Lancet about setting up a phase II trial on Ukrain in England 90.00%
NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer. Results of a phase II trial 85.00%
The ibogaine medical subculture. 85.00%
Ibogaine 80.00%
Ukrain: Debated Subjects 80.00%
Impact of complementary treatment of breast cancer patients with standardized mistletoe extract during aftercare: a controlled m 80.00%
Ukrain Debate 1: What is the active Substance of Ukrain? 80.00%
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador) 80.00%
Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression. 80.00%
Potential therapeutic efficacy of Ukrain (NSC 631570) in AIDS patients with Kaposi's sarcoma 80.00%
Ukrain therapy of recurrent breast cancer with lung metastases (case report) 80.00%
Ukrain monotherapy in malignant melanoma (case report) 80.00%
Comparison of chemotherapy and X-ray therapy with Ukrain monotherapy for colorectal cancer 80.00%
Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort 80.00%
Effects of pomegranate juice on human cytochrome P450 2C9 and tolbutamide pharmacokinetics in rats. 75.00%
The clinical efficacy of adjuvant systemic chemotherapy with gemcitabine and NSC-631570 in advanced pancreatic cancer. 75.00%
Intravenous ketamine therapy in a patient with a treatment-resistant major depression. 70.00%
Ukrain treatment in carcinoma of the oesophagus (case report) 70.00%
Ukrain treatment in a patient with breast carcinoma 70.00%
Efficacy of ukrain in the treatment of pancreatic cancer. 70.00%
Ketamine in the treatment of Depression 70.00%
Preliminary results of individual therapy of chronic hepatitis C by Ukrain and interferon-alpha. 70.00%
Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. 65.00%
Evaluation of Ukrain as an immunostimulant in patients with various carcinomas. 63.33%
Chelidonium majus L. (Ukrain) in the treatment of cancer patients. 63.33%
Ukrain 62.22%
Clinical studies of Ukrain in healthy volunteers (phase 1). 60.00%
Fruit and berries--interactions with drugs 60.00%
Combined therapy with Ukrain and chemotherapy in ovarian cancer (case report) 60.00%
Ukrain both as an anti cancer and immunoregulatory agent 60.00%
Ukrain treatment in carcinoma of the cervix (case report) 60.00%
Preliminary studies on the effect of Ukrain on the immunological response in patients with malignant tumours. 60.00%
Ukrain therapy of stage T1N0M0 bladder cancer patients 60.00%
Biophysiological effects of Ukrain therapy in a patient with breast cancer (case report) 60.00%
The effects of thiophosphoric acid (Ukrain) on cervical cancer, stage IB bulky 60.00%
Increased Response to Ketamine Following Treatment at Long Intervals: Implications for Intermittent Use. 60.00%
New biochemical mechanisms of the anticancer effect of Ukrain in the treatment of cancer of the urinary bladder 60.00%
Lymphocyte subsets in patients with lung cancer treated with thiophosphoric acid 55.00%
Ukrain treatment in a patient with metastatic renal cell carcinoma extending to the vena cava inferior. 50.00%
Results of Ukrain monotherapy of prostate cancer 50.00%
Ukrain treatment in a patient with non-seminomatous germ-cell tumour of testis (case report) 50.00%
Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus u 50.00%
Ukrain modulates glial fibrillary acidic protein, but not connexin 43 expression, and induces apoptosis in human cultured gliobl 50.00%
Comparative evaluation of blood plasma and tumor tissue amino acid pool in radiation or neoadjuvant preoperative therapies.... 50.00%
Ukrain in the treatment of urethral recurrent carcinoma (case report) 50.00%
Ukrain with chemotherapy in malignant melanoma (case report) 50.00%
Mistletoe in conventional oncological practice: exemplary cases. 40.00%
Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report) 40.00%
Ukrain treatment of a patient with retroperitoneal synovial sarcoma. 35.00%
Clinical aspects of cancer treatment and new biochemical mechanisms of the drug Ukrain. 20.00%
Cancer Treatments 20.00%
Ukrain therapy of a recurrent astrocytoma of the optic nerve (case report) 20.00%
Chemotherapy 0.00%